home / stock / avhhl / avhhl news


AVHHL News and Press, Avita Therapeutics From 02/22/24

Stock Information

Company Name: Avita Therapeutics
Stock Symbol: AVHHL
Market: OTC
Website: avitamedical.com

Menu

AVHHL AVHHL Quote AVHHL Short AVHHL News AVHHL Articles AVHHL Message Board
Get AVHHL Alerts

News, Short Squeeze, Breakout and More Instantly...

AVHHL - AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript

2024-02-22 23:03:08 ET AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Conference Call February 22, 2024 04:30 PM ET Company Participants Jessica Ekeberg - Director, IR Jim Corbett - CEO David O'Toole - CFO Conference Call Participants Brooks O'Neil - Lak...

AVHHL - AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the fourth quarter and full-yea...

AVHHL - AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

VALENCIA, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced that it will report its fourth quarter and f...

AVHHL - AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced it has entered...

AVHHL - AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

VALENCIA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced preliminary un...

AVHHL - AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

VALENCIA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices and autologous cellular therapies for skin restoration, today announced that Jim Corbett, Chief Executive Officer, w...

AVHHL - AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference

VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ann...

AVHHL - AVITA Medical Updates Full Year 2023 Guidance

VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ann...

AVHHL - AVITA Medical, Inc. (RCEL) Q3 2023 Earnings Call Transcript

2023-11-09 20:39:04 ET AVITA Medical, Inc. (RCEL) Q3 2023 Results Conference Call November 09, 2023 04:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Officer David O’Toole - Chief Financial Offi...

AVHHL - AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year

VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “ Company ”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, tod...

Previous 10 Next 10